Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine

Virology

Volumn 308, Issue 2, 2003, Pages 270-278

  Bright, Rick A ^a,b   Ross, Ted M ^c   Subbarao, Kanta ^a   Robinson, Harriet L ^b   Katz, Jacqueline M ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b EMORY UNIVERSITY   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Avian influenza; DNA vaccines; Glycosylation; H5N1; Hemagglutinin

Indexed keywords

DNA VACCINE; GLYCOPROTEIN; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; VIRUS HEMAGGLUTININ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; INFLUENZA; INFLUENZA VIRUS; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; VACCINATION; VIRUS STRAIN;

AVES; INFLUENZA VIRUS; MURINAE;

EID: 0344406204     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00008-4     Document Type: Article

References (43)

1. Bender C., Hall H., Huang J., Klimov A., Cox N., Hay A., Gregory V., Cameron K., Lim W., Subbarao K. Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998. Virology. 254:(1):1999;115-123.
2. Boyle C.M., Morin M., Webster R.G., Robinson H.L. Role of different lymphoid tissues in the initiation and maintenance of DNA-raised antibody responses to the influenza virus H1 glycoprotein. J. Virol. 70:(12):1996;9074-9078.
3. Caton A.J., Brownlee G.G., Yewdell J.W., Gerhard W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell. 31:(2 Pt.1):1982;417-427.
4. Cauthen A.N., Swayne D.E., Schultz-Cherry S., Perdue M.L., Suarez D.L. Continued circulation in China of highly pathogenic avian influenza viruses encoding the hemagglutinin gene associated with the 1997 H5N1 outbreak in poultry and humans. J. Virol. 74:(14):2000;6592-6599.
5. Isolation of avian influenza A(H5N1) viruses from humans - Hong Kong, May-December 1997. 1997;Centers for Disease Control, Atlanta, GA.
6. Update isolation of avian influenza A(H5N1) viruses from humans - Hong Kong 1997-1998 . 1998;Center for Disease Control, Atlanta, GA.
7. Donnelly J.J., Friedman A., Martinez D., Montgomery D.L., Shiver J.W., Motzel S.L., Ulmer J.B., Liu M.A. Preclinical efficacy of a prototype DNA vaccine enhanced protection against antigenic drift in influenza virus . Nat. Med. 1:(6):1995;583-587.
8. Dowdle W.R., Downie J.C., Laver W.G. Inhibition of virus release by antibodies to surface antigens of influenza viruses. J. Virol. 13:(2):1974;269-275.
9. Epstein, S.L., Tumpey, T.M., Misplon, J.A., Lo, C., Cooper, L.A., Subbarao, K., Renshaw, M., Sambhara, S., Katz, J.M. 2002. DNA vaccine expressing conserved influenza proteins protective against H5N1 challenge infection in mice. Emerging Infect. Dis. 8, 796-801.
10. Guan Y., Shortridge K.F., Krauss S., Chin P.S., Dyrting K.C., Ellis T.M., Webster R.G., Peiris M. H9N2 influenza viruses possessing H5N1-like internal genomes continue to circulate in poultry in southeastern China. J. Virol. 74:(20):2000;9372-9380.
11. Ha Y., Stevens D.J., Skehel J.J., Wiley D.C. X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs. Proc. Natl. Acad. Sci. USA. 98:(20):2001;11181-11186.
12. Harmon M.W., Rota P.A., Walls H.H., Kendal A.P. Antibody response in humans to influenza virus type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection. J. Clin. Microbiol. 26:(2):1988;333-337.
13. Haynes J.R., Fuller D.H., Eisenbraun M.D., Ford M.J., Pertmer T.M. Accell particle-mediated DNA immunization elicits humoral, cytotoxic, and protective immune responses. AIDS Res. Hum. Retroviruses. 10:(Suppl. 2):1994;S43-S45.
14. Justewicz D.M., Morin M.J., Robinson H.L., Webster R.G. Antibody-forming cell response to virus challenge in mice immunized with DNA encoding the influenza virus hemagglutinin. J. Virol. 69:(12):1995;7712-7717.
15. Katz J.M., Lu X., Young S.A., Galphin J.C. Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine. J. Infect. Dis. 175:(2):1997;352-363.
16. Kaverin N.V., Rudneva I.A., Ilyushina N.A., Varich N.L., Lipatov A.S., Smirnov Y.A., Govorkova E.A., Gitelman A.K., Lvov D.K., Webster R.G. Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants. J. Gen. Virol. 83:(Pt 10):2002;2497-2505.
17. Keil W., Niemann H., Schwarz R.T., Klenk H.D. Carbohydrates of influenza virus. V. Oligosaccharides attached to individual glycosylation sites of the hemagglutinin of fowl plague virus. Virology. 133:(1):1984;77-91.
18. Kendal A.P., Skehel J.J., Pereira M.S. Concepts and procedures for laboratory-based influenza surveillance. 1982;B17-B35 Centers for Disease Control, Atlanta, GA.
19. Kent S.J., Cameron P.U., Reece J.C., Thompson P.R., Purcell D.F. Attenuated and wild-type HIV-1 infections and long terminal repeat-mediated gene expression from plasmids delivered by gene gun to human skin ex vivo and macaques in vivo. Virology. 287:(1):2001;71-78.
20. Kilbourne E.D., Kehoe J.M. Demonstration of antibodies to both hemagglutinin and neuraminidase antigens of H3N2 influenza A virus in domestic dogs. Intervirology. 6:(4-5):1975;315-318.
21. Kodihalli S., Goto H., Kobasa D.L., Krauss S., Kawaoka Y., Webster R.G. DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. J. Virol. 73:(3):1999;2094-2098.
22. Lodmell D.L., Parnell M.J., Bailey J.R., Ewalt L.C., Hanlon C.A. One-time gene gun or intramuscular rabies DNA vaccination of non-human primates comparison of neutralizing antibody responses and protection against rabies virus 1 year after vaccination . Vaccine. 20:(5-6):2001;838-844.
23. Lu X., Tumpey T.M., Morken T., Zaki S.R., Cox N.J., Katz J.M. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J. Virol. 73:(7):1999;5903-5911.
24. Matrosovich M., Zhou N., Kawaoka Y., Webster R. The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. Journal of Virology. 73:(2):1999;1146-1155.
25. Nicholson K.G., Colegate A.E., Podda A., Stephenson I., Wood J., Ypma E., Zambon M.C. Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine a randomised trial of two potential vaccines against H5N1 influenza . Lancet. 357:(9272):2001;1937-1943.
26. Pertmer T.M., Eisenbraun M.D., McCabe D., Prayaga S.K., Fuller D.H., Haynes J.R. Gene gun-based nucleic acid immunization elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA . Vaccine. 13:(15):1995;1427-1430.
27. Pertmer T.M., Robinson H.L. Studies on antibody responses following neonatal immunization with influenza hemagglutinin DNA or protein. Virology. 257:(2):1999;406-414.
28. Quinones-Kochs M.I., Buonocore L., Rose J.K. Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein effects on protein function and the neutralizing antibody response . J. Virol. 76:(9):2002;4199-4211.
29. Raymond F.L., Caton A.J., Cox N.J., Kendal A.P., Brownlee G.G. The antigenicity and evolution of influenza H1 haemagglutinin, from 1950-1957 and 1977-1983 two pathways from one gene . Virology. 148:(2):1986;275-287.
30. Richmond J.Y., McKinney R.W. Laboratory biosafety level criteria. Richmond J.Y., McKinney R.W. Biosafety in Microbiological and Biomedical Laboratores. 3rd ed. 1993;16-43 Centers for Disease Control, Atlanta, GA.
31. Ross T.M., Xu Y., Bright R.A., Robinson H.L. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat. Immunol. 1:(2):2000;127-131.
32. Rowe T., Abernathy R.A., Hu-Primmer J., Thompson W.W., Lu X., Lim W., Fukuda K., Cox N.J., Katz J.M. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J. Clin. Microbiol. 37:(4):1999;937-943.
33. Skehel J.J., Stevens D.J., Daniels R.S., Douglas A.R., Knossow M., Wilson I.A., Wiley D.C. A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc. Natl. Acad. Sci. USA. 81:(6):1984;1779-1783.
34. Subbarao K., Klimov A., Katz J., Regnery H., Lim W., Hall H., Perdue M., Swayne D., Bender C., Huang J., Hemphill M., Rowe T., Shaw M., Xu X., Fukuda K., Cox N. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science. 279:(5349):1998;393-396.
35. Takada A., Kuboki N., Okazaki K., Ninomiya A., Tanaka H., Ozaki H., Itamura S., Nishimura H., Enami M., Tashiro M., Shortridge K.F., Kida H. Avirulent avian influenza virus as a vaccine strain against a potential human pandemic. J. Virol. 73:(10):1999;8303-8307.
36. Treanor J.J., Wilkinson B.E., Masseoud F., Hu-Primmer J., Battaglia R., O'Brien D., Wolff M., Rabinovich G., Blackwelder W., Katz J.M. Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. Vaccine. 19:(13-14):2001;1732-1737.
37. Webster R.G., Guan Y., Peiris M., Walker D., Krauss S., Zhou N.N., Govorkova E.A., Ellis T.M., Dyrting K.C., Sit T., Perez D.R., Shortridge K.F. Characterization of H5N1 influenza viruses that continue to circulate in geese in southeastern China. J. Virol. 76:(1):2002;118-126.
38. Webster R.G., Laver W.G., Tumova B. Studies on the origin of pandemic influenza viruses V. Persistence of Asian influenza virus hemagglutinin (H2) antigen in nature? Virology. 67:(2):1975;534-543.
39. Wiley D.C., Skehel J.J. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem. 56:1987;365-394.
40. Wiley D.C., Wilson I.A., Skehel J.J. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature. 289:(5796):1981;373-378.
41. Wilson I.A., Cox N.J. Structural basis of immune recognition of influenza virus hemagglutinin. Annu. Rev. Immunol. 8:1990;737-771.
42. Wilson I.A., Ladner R.C., Skehel J.J., Wiley D.C. The structure and role of the carbohydrate moieties of influenza virus haemagglutinin. Biochem. Soc. Trans. 11:(2):1983;145-147.
43. Wood J.M., Major D., Daly J., Newman R.W., Dunleavy U., Nicolson C., Robertson J.S., Schild G.C., Lee-Lin Y.N. Vaccines against H5N1 influenza. Vaccine. 18:(7-8):1999;579-580.